TickerFactsScreenerDevelopers

Eloxx Pharmaceuticals, Inc. (ELOX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$4.85M2011: -$7.92M2012: -$5.41M2013: -$4.65M2014: -$9.15M2015: -$6.28M2016: -$9.84M2017: -$20.39M2018: -$47.56M2019: -$50.55M2020: -$33.45M2021: -$66.02M2022: -$34.42M2023: -$17.29M2024: -$2.47M2025: -$6.44M-$6.44M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$6.44M-160.9%
2024-$2.47M+85.7%
2023-$17.29M+49.8%
2022-$34.42M+47.9%
2021-$66.02M-97.3%
2020-$33.45M+33.8%
2019-$50.55M-6.3%
2018-$47.56M-133.3%
2017-$20.39M-107.2%
2016-$9.84M-56.6%
2015-$6.28M+31.3%
2014-$9.15M-96.7%
2013-$4.65M+14.1%
2012-$5.41M+31.7%
2011-$7.92M-63.4%
2010-$4.85M—